Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.05
THC's Cash-to-Debt is ranked lower than
80% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. THC: 0.05 )
Ranked among companies with meaningful Cash-to-Debt only.
THC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.05 Max: 0.29
Current: 0.05
0
0.29
Equity-to-Asset 0.02
THC's Equity-to-Asset is ranked lower than
93% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. THC: 0.02 )
Ranked among companies with meaningful Equity-to-Asset only.
THC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.01  Med: 0.15 Max: 0.41
Current: 0.02
0.01
0.41
Interest Coverage 1.25
THC's Interest Coverage is ranked lower than
91% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 7.25 vs. THC: 1.25 )
Ranked among companies with meaningful Interest Coverage only.
THC' s Interest Coverage Range Over the Past 10 Years
Min: 0.66  Med: 1.24 Max: 1.82
Current: 1.25
0.66
1.82
Piotroski F-Score: 5
Altman Z-Score: 0.96
WACC vs ROIC
4.79%
7.12%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 6.21
THC's Operating Margin % is ranked lower than
52% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. THC: 6.21 )
Ranked among companies with meaningful Operating Margin % only.
THC' s Operating Margin % Range Over the Past 10 Years
Min: 3.41  Med: 5.98 Max: 8.21
Current: 6.21
3.41
8.21
Net Margin % -0.98
THC's Net Margin % is ranked lower than
76% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. THC: -0.98 )
Ranked among companies with meaningful Net Margin % only.
THC' s Net Margin % Range Over the Past 10 Years
Min: -1.21  Med: 0.18 Max: 13.5
Current: -0.98
-1.21
13.5
ROE % -34.48
THC's ROE % is ranked lower than
92% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. THC: -34.48 )
Ranked among companies with meaningful ROE % only.
THC' s ROE % Range Over the Past 10 Years
Min: -55.97  Med: 2.68 Max: 92.79
Current: -34.48
-55.97
92.79
ROA % -0.79
THC's ROA % is ranked lower than
75% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. THC: -0.79 )
Ranked among companies with meaningful ROA % only.
THC' s ROA % Range Over the Past 10 Years
Min: -1.05  Med: 0.19 Max: 13.89
Current: -0.79
-1.05
13.89
ROC (Joel Greenblatt) % 14.71
THC's ROC (Joel Greenblatt) % is ranked lower than
53% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. THC: 14.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
THC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4.8  Med: 12.1 Max: 15.25
Current: 14.71
4.8
15.25
3-Year Revenue Growth Rate 21.90
THC's 3-Year Revenue Growth Rate is ranked higher than
89% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. THC: 21.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
THC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -13.7  Med: 0.3 Max: 32.4
Current: 21.9
-13.7
32.4
3-Year EBITDA Growth Rate 35.20
THC's 3-Year EBITDA Growth Rate is ranked higher than
92% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. THC: 35.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
THC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -47.1  Med: 11.6 Max: 35.2
Current: 35.2
-47.1
35.2
3-Year EPS without NRI Growth Rate 15.80
THC's 3-Year EPS without NRI Growth Rate is ranked higher than
63% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. THC: 15.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
THC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -72.8  Med: -1.35 Max: 57
Current: 15.8
-72.8
57
GuruFocus has detected 3 Warning Signs with Tenet Healthcare Corp $THC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» THC's 10-Y Financials

Financials (Next Earnings Date: 2017-05-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

THC Guru Trades in Q1 2016

David Tepper 348,405 sh (New)
George Soros 31,700 sh (New)
Mario Gabelli 15,050 sh (+0.07%)
Larry Robbins 17,890,230 sh (unchged)
Paul Tudor Jones Sold Out
Louis Moore Bacon Sold Out
» More
Q2 2016

THC Guru Trades in Q2 2016

Joel Greenblatt 545,902 sh (New)
Larry Robbins 17,890,230 sh (unchged)
George Soros Sold Out
David Tepper Sold Out
Mario Gabelli 15,000 sh (-0.33%)
» More
Q3 2016

THC Guru Trades in Q3 2016

Paul Tudor Jones 45,786 sh (New)
Steven Cohen 415,400 sh (New)
Mario Gabelli 15,000 sh (unchged)
Larry Robbins 17,890,230 sh (unchged)
Joel Greenblatt 22,489 sh (-95.88%)
» More
Q4 2016

THC Guru Trades in Q4 2016

George Soros 13,500 sh (New)
Paul Singer 1,494,358 sh (New)
Michael Price 250,000 sh (New)
Jim Simons 1,325,875 sh (New)
Larry Robbins 17,890,230 sh (unchged)
Joel Greenblatt Sold Out
Mario Gabelli Sold Out
Paul Tudor Jones 24,300 sh (-46.93%)
Steven Cohen 5,300 sh (-98.72%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:OTCPK:RAFLF, NAS:AMED, NYSE:SEM, NYSE:AMN, NAS:SCAI, NAS:TVTY, NAS:PAHC, NAS:LPNT, NYSE:CYH, NAS:SGRY, NAS:LHCG, NYSE:USPH, OTCPK:LTGHY, NAS:AFAM, OTCPK:COLRF, NAS:PRSC, NYSE:CHE, OTCPK:RLGHF, OTCPK:MFCSF, NAS:ADUS » details
Traded in other countries:THC1.Germany,
Tenet Healthcare Corp is a health care services company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks.

Based in Dallas, Tenet Healthcare is one of the largest acute-care firms in the U.S., accounting for roughly 2% of the country's hospital admissions. It operates 79 acute-care hospitals with more than 20,000 beds, as well as over 475 ambulatory surgery centers, diagnostic imaging centers, and urgent care centers, and a revenue cycle subsidiary called Conifer. Tenet has facilities in numerous states, with most of its total operations in California, Florida, and Texas. Outpatient services make up about 36% of Tenet's patient revenue.

Ratios

vs
industry
vs
history
Forward PE Ratio 13.76
THC's Forward PE Ratio is ranked higher than
83% of the 83 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. THC: 13.76 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 4.05
THC's PB Ratio is ranked lower than
76% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. THC: 4.05 )
Ranked among companies with meaningful PB Ratio only.
THC' s PB Ratio Range Over the Past 10 Years
Min: 1.39  Med: 5.23 Max: 100.25
Current: 4.05
1.39
100.25
PS Ratio 0.09
THC's PS Ratio is ranked higher than
97% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. THC: 0.09 )
Ranked among companies with meaningful PS Ratio only.
THC' s PS Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.3 Max: 0.56
Current: 0.09
0.05
0.56
Price-to-Free-Cash-Flow 6.66
THC's Price-to-Free-Cash-Flow is ranked higher than
91% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 23.68 vs. THC: 6.66 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
THC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.06  Med: 40.42 Max: 514.15
Current: 6.66
2.06
514.15
Price-to-Operating-Cash-Flow 3.01
THC's Price-to-Operating-Cash-Flow is ranked higher than
95% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 13.47 vs. THC: 3.01 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
THC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.31  Med: 6.51 Max: 15.63
Current: 3.01
1.31
15.63
EV-to-EBIT 13.79
THC's EV-to-EBIT is ranked higher than
72% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. THC: 13.79 )
Ranked among companies with meaningful EV-to-EBIT only.
THC' s EV-to-EBIT Range Over the Past 10 Years
Min: -273.8  Med: 13.8 Max: 1337.9
Current: 13.79
-273.8
1337.9
EV-to-EBITDA 8.09
THC's EV-to-EBITDA is ranked higher than
84% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 14.29 vs. THC: 8.09 )
Ranked among companies with meaningful EV-to-EBITDA only.
THC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -34  Med: 8.15 Max: 22.6
Current: 8.09
-34
22.6
Shiller PE Ratio 23.13
THC's Shiller PE Ratio is ranked higher than
62% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.74 vs. THC: 23.13 )
Ranked among companies with meaningful Shiller PE Ratio only.
THC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.05  Med: 56.24 Max: 301.91
Current: 23.13
20.05
301.91
Current Ratio 1.30
THC's Current Ratio is ranked higher than
52% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. THC: 1.30 )
Ranked among companies with meaningful Current Ratio only.
THC' s Current Ratio Range Over the Past 10 Years
Min: 1.11  Med: 1.39 Max: 1.96
Current: 1.3
1.11
1.96
Quick Ratio 1.22
THC's Quick Ratio is ranked higher than
54% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.16 vs. THC: 1.22 )
Ranked among companies with meaningful Quick Ratio only.
THC' s Quick Ratio Range Over the Past 10 Years
Min: 1.03  Med: 1.31 Max: 1.85
Current: 1.22
1.03
1.85
Days Inventory 9.27
THC's Days Inventory is ranked higher than
70% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 18.84 vs. THC: 9.27 )
Ranked among companies with meaningful Days Inventory only.
THC' s Days Inventory Range Over the Past 10 Years
Min: 8.92  Med: 10.35 Max: 13.35
Current: 9.27
8.92
13.35
Days Sales Outstanding 53.89
THC's Days Sales Outstanding is ranked lower than
66% of the 174 Companies
in the Global Medical Care industry.

( Industry Median: 44.22 vs. THC: 53.89 )
Ranked among companies with meaningful Days Sales Outstanding only.
THC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.89  Med: 53.87 Max: 62.54
Current: 53.89
46.89
62.54
Days Payable 38.87
THC's Days Payable is ranked lower than
51% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. THC: 38.87 )
Ranked among companies with meaningful Days Payable only.
THC' s Days Payable Range Over the Past 10 Years
Min: 38.87  Med: 47.66 Max: 56.74
Current: 38.87
38.87
56.74

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.00
THC's 3-Year Average Share Buyback Ratio is ranked higher than
65% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. THC: -1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
THC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.7  Med: -0.5 Max: 7.3
Current: -1
-1.7
7.3

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.75
THC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
86% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. THC: 0.75 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
THC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.66  Med: 1.38 Max: 4.06
Current: 0.75
0.66
4.06
Price-to-Median-PS-Value 0.29
THC's Price-to-Median-PS-Value is ranked higher than
96% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. THC: 0.29 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
THC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.21  Med: 1.36 Max: 5.98
Current: 0.29
0.21
5.98
Earnings Yield (Greenblatt) % 7.29
THC's Earnings Yield (Greenblatt) % is ranked higher than
77% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.94 vs. THC: 7.29 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
THC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 7 Max: 15.7
Current: 7.29
0.1
15.7
Forward Rate of Return (Yacktman) % 36.78
THC's Forward Rate of Return (Yacktman) % is ranked higher than
94% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 10.02 vs. THC: 36.78 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
THC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -103.1  Med: 0.5 Max: 38.5
Current: 36.78
-103.1
38.5

More Statistics

Revenue (TTM) (Mil) $19,621
EPS (TTM) $ -1.93
Beta1.02
Short Percentage of Float20.35%
52-Week Range $14.06 - 34.08
Shares Outstanding (Mil)99.81

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 19,710 20,866 21,983
EPS ($) 1.48 1.47 2.36
EPS without NRI ($) 1.48 1.47 2.36
EPS Growth Rate
(Future 3Y To 5Y Estimate)
32.71%
Dividends per Share ($)
» More Articles for THC

Headlines

Articles On GuruFocus.com
8 of the Worst Stocks in Gurus' Portfolios Feb 20 2017 
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Dec 06 2015 
Insiders Buy Stock in Wynn Resorts, Bank of New York Mellon Oct 25 2015 
Larry Robbins Raises Stake in Tenet Healthcare Oct 05 2015 
Obamacare Makes HCA a Buy Aug 24 2015 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Distressed Debt Investor Paul Singer Buys Citrix Systems Jun 11 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Tenet Healthcare And United Surgical JV For $1.93 Billion Mar 24 2015 

More From Other Websites
White House, House Leaders Put It All on Table For Healthcare Reform Mar 23 2017
Healthcare Stocks Await TrumpCare Vote Mar 23 2017
Today's charts: Community Health Systems, HCA Holdings, Tenet Healthcare gain ahead of health care... Mar 23 2017
GOP Health Bill Threatens to Throw Free-Care Burden Back on Hospitals Mar 17 2017
Post Earnings Coverage as Tenet's Q4 Results Missed Market Expectations Mar 15 2017
Health Care Stocks Socked Again After CBO RyanCare Score Mar 14 2017
Tenet Healthcare (THC) Signs Multi-Year Deal with BCBSTX Mar 14 2017
Tenet Healthcare Corp. breached its 50 day moving average in a Bearish Manner : THC-US : March 14,... Mar 14 2017
US STOCKS-Wall St ends up; jobs data points to economic strength Mar 10 2017
Tenet and Blue Cross and Blue Shield of Texas Sign Multi-Year Agreement Mar 10 2017
6 Reasons to Shun Tenet Healthcare (THC) Stock For Now Mar 09 2017
Tenet to Participate in the Barclays Global Healthcare Conference on March 14, 2017 Mar 09 2017
Democrats fight Trump-backed U.S. healthcare plan, Ryan defends it Mar 08 2017
Chaos Is Biggest Threat to Wednesday's Vote on Repealing Obamacare Mar 08 2017
Trump rally on pause: Stocks, Dow Jones sluggish despite strong ADP jobs report: Snap, Goldman,... Mar 08 2017
House panels to launch fight in Congress over Obamacare replacement Mar 08 2017
Stocks: Ready for Trump rally rebound or third straight down day and bigger retreat from Dow 21K? Mar 07 2017
Conservatives rebel against Trump-backed Republican healthcare plan Mar 07 2017
Are There Any Winners From The GOP Health Care Plan? Mar 07 2017
Will Obamacare Repeal Make Healthcare Stocks Sick? Mar 07 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)